Patton Albertson Miller Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.27M Sell
12,507
-56
-0.4% -$26.9K 0.62% 47
2026
Q1
$6.18M Buy
12,563
+342
+3% +$186K 0.73% 42
2025
Q4
$7.08M Buy
12,221
+54
+0.4% +$30.5K 0.83% 34
2025
Q3
$5.9M Buy
12,167
+45
+0.4% +$20.9K 0.71% 42
2025
Q2
$4.91M Buy
12,122
+1,164
+11% +$487K 0.65% 51
2025
Q1
$5.45M Sell
10,958
-3,488
-24% -$1.89M 0.81% 43
2024
Q4
$7.52M Buy
14,446
+500
+4% +$275K 1.01% 33
2024
Q3
$8.63M Sell
13,946
-479
-3% -$284K 1.17% 23
2024
Q2
$7.98M Buy
14,425
+904
+7% +$518K 1.13% 23
2024
Q1
$7.86M Buy
13,521
+952
+8% +$534K 1.18% 24
2023
Q4
$6.67M Buy
12,569
+1,544
+14% +$747K 1.11% 25
2023
Q3
$5.58M Buy
11,025
+78
+0.7% +$41.6K 1.09% 27
2023
Q2
$5.71M Sell
10,947
-80
-0.7% -$43.2K 1.1% 23
2023
Q1
$6.36M Buy
11,027
+149
+1% +$84K 1.16% 19
2022
Q4
$5.99M Sell
10,878
-190
-2% -$101K 1.1% 20
2022
Q3
$5.61M Buy
11,068
+222
+2% +$124K 1.21% 19
2022
Q2
$5.89M Sell
10,846
-75
-0.7% -$41.3K 1.2% 15
2022
Q1
$6.45M Sell
10,921
-40
-0.4% -$23K 1.11% 19
2021
Q4
$7.31M Buy
10,961
+566
+5% +$353K 1.18% 17
2021
Q3
$5.94M Buy
10,395
+2,748
+36% +$1.51M 1.14% 16
2021
Q2
$3.86M Buy
7,647
+137
+2% +$64.6K 0.88% 32
2021
Q1
$3.43M Buy
7,510
+22
+0.3% +$10.5K 0.83% 35
2020
Q4
$3.75M Sell
7,488
-43
-0.6% -$20.2K 0.89% 27
2020
Q3
$3.33M Sell
7,531
-380
-5% -$157K 0.94% 27
2020
Q2
$2.87M Sell
7,911
-112
-1% -$37.5K 0.83% 32
2020
Q1
$2.27M Sell
8,023
-173
-2% -$54.6K 0.77% 36
2019
Q4
$2.66M Buy
8,196
+281
+4% +$85.2K 0.7% 40
2019
Q3
$2.31M Sell
7,915
-106
-1% -$30.4K 0.65% 47
2019
Q2
$2.22M Buy
8,021
+449
+6% +$124K 0.64% 52
2019
Q1
$2.07M Buy
7,572
+94
+1% +$23.4K 1.05% 30
2018
Q4
$1.83M Sell
7,478
-353
-5% -$82.8K 0.98% 26
2018
Q3
$1.73M Sell
7,831
-264
-3% -$60.7K 0.88% 31
2018
Q2
$1.68M Sell
8,095
-144
-2% -$30.6K 0.85% 38
2018
Q1
$1.7M Sell
8,239
-70
-0.8% -$14.7K 0.76% 40
2017
Q4
$1.58M Buy
8,309
+32
+0.4% +$6.13K 0.64% 49
2017
Q3
$1.6M Buy
8,277
+729
+10% +$132K 0.7% 44
2017
Q2
$1.32M Sell
7,548
-771
-9% -$130K 0.59% 57
2017
Q1
$1.43M Buy
8,319
+449
+6% +$68.6K 0.59% 53
2016
Q4
$1.11M Sell
7,870
-280
-3% -$41.3K 0.47% 66
2016
Q3
$1.3M Sell
8,150
-1,212
-13% -$187K 0.57% 53
2016
Q2
$1.38M Sell
9,362
-1,642
-15% -$242K 0.62% 46
2016
Q1
$1.56M Sell
11,004
-149
-1% -$20K 0.79% 43
2015
Q4
$1.58M Sell
11,153
-102
-0.9% -$13.6K 0.8% 45
2015
Q3
$1.37M Sell
11,255
-752
-6% -$98K 0.73% 56
2015
Q2
$1.56M Buy
12,007
+1,214
+11% +$158K 0.68% 67
2015
Q1
$1.45M Buy
10,793
+3,926
+57% +$506K 0.59% 71
2014
Q4
$860K Buy
6,867
+1,808
+36% +$220K 0.4% 88
2014
Q3
$614K Buy
5,059
+2,295
+83% +$279K 0.32% 99
2014
Q2
$327K Buy
2,764
+721
+35% +$84.9K 0.17% 136
2014
Q1
$246K Buy
+2,043
New +$243K 0.13% 151

Other funds holding TMO

Patton Albertson Miller Group's TMO Position: Q2 2026 in Review

Patton Albertson Miller Group reduced its Thermo Fisher Scientific (TMO) stake by 0.45% in Q2 2026, selling an estimated $26.9K and leaving 12,507 shares worth $6.27M. The position accounts for 0.62% of the portfolio, ranked #47.

Patton Albertson Miller Group first reported a position in TMO in Q1 2014 and has held it in 50 quarters since. The position peaked at $8.63M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Patton Albertson Miller Group held 12,507 shares of Thermo Fisher Scientific worth $6.27M as of Q2 2026.
  • Patton Albertson Miller Group sold 56 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.9K.
  • Thermo Fisher Scientific made up 0.62% of Patton Albertson Miller Group's portfolio in Q2 2026, its #47 holding.
  • Patton Albertson Miller Group first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 50 quarters since.
  • Patton Albertson Miller Group's Thermo Fisher Scientific position peaked at $8.63M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.